Fact CheckerSign in

NCT06795308Not yet recruiting

The Effect of Position on Pain, Bleeding, Hematoma and Vital Signs After Transfemoral Coronary Angiography

Source: ClinicalTrials.gov · Last updated 5 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In this study, it was aimed to determine the effect of the special position given to the patient after transfemoral coronary angiography (supine position that varies depending on the angles) on pain, bleeding, hematoma and vital signs.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
5 Dec 2024
Start date
3 Feb 2025
Primary completion date
30 May 2025
Lead sponsor
Mersin University
NCT number
NCT06795308

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 3 Feb 2025 to the primary completion date, 30 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously treated with streptokinase
  • Those who have had back surgery/herniated disc,

Other illness

  • Those with active hemorrhage

Other

  • People with hemophilia or other coagulation defects
  • Using more than 2 anticoagulants or antiplatelets
  • Having chronic waist, back or leg pain
  • Using any of the complementary and integrated methods
  • Do not use any analgesic before, during and after transfemoral angiography.
  • Radial angiography procedure was performed
  • Patients coming to the service with sandbags
  • Those who had any health problems or lost their lives during the application process
  • Those who cannot continue the research for any reason
  • Patients who wish to leave the study with their own consent

Who the study is looking for

  • Written and verbal permission was obtained to participate in the research.
  • Able to read, write, speak and understand Turkish
  • Those who are over 18 years old
  • Planned transfemoral angiography was performed
  • Having normal prothrombin time (PT) and international normalization ratio (INR)
  • Being conscious, fully oriented and cooperative, and open to communication.
  • Those whose general condition is good and comfortable (vital signs are within normal limits)
  • Not using any sedative medication,
  • Those who have not previously had widespread hemorrhage, large hematoma, or a pain sensation greater than 4.5 on the visual pain scale
  • Patients with imaging, medical treatment, stents, balloons, stents and balloons as a result of the procedure
  • Not having any psychiatric disease

Age in the registry: 18 hours to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Adana City Training and Research Hospital
Coordinator of this site? Confirm its status
AdanaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.